Cyclerion Therapeutics's total assets for Q1 2025 were $9.85M, an increase of 2.84% from the previous quarter. CYCN total liabilities were $1.07M for the fiscal quarter, a 47.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.